{"transactions":[{"id":2148450,"issuer":{"id":7541,"kind":"organization","name":"TherapeuticsMD, Inc."},"owners":[{"id":123438,"kind":"person","name":"MUSING JULES A.","position":1,"cik":"0001524216","reported_name":"MUSING JULES A.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2022-10-03T22:38:38.000Z","date":"2022-09-29","kind":"grant","acquired":true,"shares":5000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive one share of common stock of the Issuer.  The RSU's will vest on September 29, 2023."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive one share of common stock of the Issuer.  The RSU's will vest on September 29, 2023."}],"balance_after":5000,"derivative":{"exercise_price":0,"underlying":"Common Stock","underlying_shares":5000},"source":{"system":"sec-edgar","filing":"0001209191-22-051958","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/25743/000120919122051958/doc4.xml","form_type":"4"}},{"id":2177782,"issuer":{"id":7541,"kind":"organization","name":"TherapeuticsMD, Inc."},"owners":[{"id":123438,"kind":"person","name":"MUSING JULES A.","position":1,"cik":"0001524216","reported_name":"MUSING JULES A.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2022-08-22T10:00:51.000Z","date":"2022-08-18","kind":"exercise","acquired":false,"shares":1984,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"On August 18, 2022, the reporting person received 1,984 shares of common stock of the issuer in settlement of restricted stock units (RSUs), which vested on July 1, 2022."},{"field":"shares","element":"transactionShares","label":"F2","text":"Each RSU represents a contingent right to receive one share of issuer common stock upon settlement."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The RSUs vested on July 1, 2022."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"The RSUs vested on July 1, 2022."},{"field":"derivative.underlying_shares","element":"underlyingSecurityShares","label":"F1","text":"On August 18, 2022, the reporting person received 1,984 shares of common stock of the issuer in settlement of restricted stock units (RSUs), which vested on July 1, 2022."},{"field":"derivative.underlying_shares","element":"underlyingSecurityShares","label":"F2","text":"Each RSU represents a contingent right to receive one share of issuer common stock upon settlement."}],"balance_after":0,"derivative":{"exercise_price":0,"underlying":"Common Stock","underlying_shares":1984},"source":{"system":"sec-edgar","filing":"0001209191-22-046967","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/25743/000120919122046967/doc4.xml","form_type":"4"}},{"id":2177781,"issuer":{"id":7541,"kind":"organization","name":"TherapeuticsMD, Inc."},"owners":[{"id":123438,"kind":"person","name":"MUSING JULES A.","position":1,"cik":"0001524216","reported_name":"MUSING JULES A.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-08-22T10:00:51.000Z","date":"2022-08-18","kind":"exercise","acquired":true,"shares":1984,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"On August 18, 2022, the reporting person received 1,984 shares of common stock of the issuer in settlement of restricted stock units (RSUs), which vested on July 1, 2022."}],"balance_after":4022,"source":{"system":"sec-edgar","filing":"0001209191-22-046967","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/25743/000120919122046967/doc4.xml","form_type":"4"}},{"id":2606313,"issuer":{"id":7541,"kind":"organization","name":"TherapeuticsMD, Inc."},"owners":[{"id":123438,"kind":"person","name":"MUSING JULES A.","position":1,"cik":"0001524216","reported_name":"MUSING JULES A.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2021-08-13T01:35:03.000Z","date":"2021-08-10","kind":"exercise","acquired":false,"shares":96864,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"On August 10, 2021, the reporting person received 96,864 shares of common stock of the issuer in settlement of restricted stock units (RSUs), which vested on June 18, 2021."},{"field":"shares","element":"transactionShares","label":"F2","text":"Each RSU represented a contingent right to receive one share of issuer common stock upon settlement."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The RSUs vested on June 18, 2021."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"The RSUs vested on June 18, 2021."},{"field":"derivative.underlying_shares","element":"underlyingSecurityShares","label":"F1","text":"On August 10, 2021, the reporting person received 96,864 shares of common stock of the issuer in settlement of restricted stock units (RSUs), which vested on June 18, 2021."},{"field":"derivative.underlying_shares","element":"underlyingSecurityShares","label":"F2","text":"Each RSU represented a contingent right to receive one share of issuer common stock upon settlement."}],"balance_after":0,"derivative":{"exercise_price":0,"underlying":"Common Stock","underlying_shares":96864},"source":{"system":"sec-edgar","filing":"0001387131-21-008438","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/25743/000138713121008438/ownership.xml","form_type":"4"}},{"id":2606312,"issuer":{"id":7541,"kind":"organization","name":"TherapeuticsMD, Inc."},"owners":[{"id":123438,"kind":"person","name":"MUSING JULES A.","position":1,"cik":"0001524216","reported_name":"MUSING JULES A.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-08-13T01:35:03.000Z","date":"2021-08-10","kind":"exercise","acquired":true,"shares":96864,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"On August 10, 2021, the reporting person received 96,864 shares of common stock of the issuer in settlement of restricted stock units (RSUs), which vested on June 18, 2021."}],"balance_after":101864,"source":{"system":"sec-edgar","filing":"0001387131-21-008438","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/25743/000138713121008438/ownership.xml","form_type":"4"}},{"id":2646990,"issuer":{"id":7541,"kind":"organization","name":"TherapeuticsMD, Inc."},"owners":[{"id":123438,"kind":"person","name":"MUSING JULES A.","position":1,"cik":"0001524216","reported_name":"MUSING JULES A.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2021-07-02T22:09:43.000Z","date":"2021-07-01","kind":"grant","acquired":true,"shares":99174,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Each restricted stock unit (RSU) represents a contingent right to receive one share of common stock of the issuer. The RSUs will vest on July 1, 2022."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Each restricted stock unit (RSU) represents a contingent right to receive one share of common stock of the issuer. The RSUs will vest on July 1, 2022."}],"balance_after":99174,"derivative":{"exercise_price":0,"underlying":"Common Stock","underlying_shares":99174},"source":{"system":"sec-edgar","filing":"0001387131-21-007135","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/25743/000138713121007135/ownership.xml","form_type":"4"}},{"id":3104962,"issuer":{"id":7541,"kind":"organization","name":"TherapeuticsMD, Inc."},"owners":[{"id":123438,"kind":"person","name":"MUSING JULES A.","position":1,"cik":"0001524216","reported_name":"MUSING JULES A.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2020-06-19T21:09:31.000Z","date":"2020-06-18","kind":"grant","acquired":true,"shares":96864,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Each restricted stock unit (RSU) represents a contingent right to receive one share of common stock of the issuer. The RSUs will vest on June 18, 2021."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Each restricted stock unit (RSU) represents a contingent right to receive one share of common stock of the issuer. The RSUs will vest on June 18, 2021."}],"balance_after":96864,"derivative":{"exercise_price":0,"underlying":"Common Stock","underlying_shares":96864},"source":{"system":"sec-edgar","filing":"0001387131-20-005818","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/25743/000138713120005818/ownership.xml","form_type":"4"}},{"id":3480829,"issuer":{"id":7541,"kind":"organization","name":"TherapeuticsMD, Inc."},"owners":[{"id":123438,"kind":"person","name":"MUSING JULES A.","position":1,"cik":"0001524216","reported_name":"MUSING JULES A.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Non-Qualified Stock Option (right to buy)","published_at":"2019-06-24T23:02:58.000Z","date":"2019-06-20","kind":"grant","acquired":true,"shares":75000,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":75000,"derivative":{"exercise_price":2.64,"exercise_date":"2020-06-20","expiration_date":"2029-06-20","underlying":"Common Stock","underlying_shares":75000},"source":{"system":"sec-edgar","filing":"0001387131-19-004587","document":"musing-form4_062019.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/25743/000138713119004587/musing-form4_062019.xml","form_type":"4"}},{"id":3625361,"issuer":{"id":7541,"kind":"organization","name":"TherapeuticsMD, Inc."},"owners":[{"id":123438,"kind":"person","name":"MUSING JULES A.","position":1,"cik":"0001524216","reported_name":"MUSING JULES A.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2019-03-01T22:30:35.000Z","date":"2019-02-27","kind":"sale","acquired":false,"shares":17400,"price":5.8,"value":100920.0,"ownership":{"direct":true},"balance_after":5000,"source":{"system":"sec-edgar","filing":"0001387131-19-001657","document":"musing-form4_022719.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/25743/000138713119001657/musing-form4_022719.xml","form_type":"4"}},{"id":3873831,"issuer":{"id":7541,"kind":"organization","name":"TherapeuticsMD, Inc."},"owners":[{"id":123438,"kind":"person","name":"MUSING JULES A.","position":1,"cik":"0001524216","reported_name":"MUSING JULES A.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Non-Qualified Stock Option (right to buy)","published_at":"2018-07-05T21:01:42.000Z","date":"2018-07-02","kind":"grant","acquired":true,"shares":50000,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":50000,"derivative":{"exercise_price":6.35,"exercise_date":"2019-07-02","expiration_date":"2028-07-02","underlying":"Common Stock","underlying_shares":50000},"source":{"system":"sec-edgar","filing":"0001387131-18-003029","document":"musing-form4_070218.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/25743/000138713118003029/musing-form4_070218.xml","form_type":"4"}},{"id":4274184,"issuer":{"id":7541,"kind":"organization","name":"TherapeuticsMD, Inc."},"owners":[{"id":123438,"kind":"person","name":"MUSING JULES A.","position":1,"cik":"0001524216","reported_name":"MUSING JULES A.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Non-Qualified Stock Option (right to buy)","published_at":"2017-06-23T20:30:40.000Z","date":"2017-06-21","kind":"grant","acquired":true,"shares":50000,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":50000,"derivative":{"exercise_price":5.8,"exercise_date":"2018-06-21","expiration_date":"2027-06-21","underlying":"Common Stock","underlying_shares":50000},"source":{"system":"sec-edgar","filing":"0001387131-17-003411","document":"musing-form4_062117.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/25743/000138713117003411/musing-form4_062117.xml","form_type":"4"}},{"id":4513932,"issuer":{"id":7541,"kind":"organization","name":"TherapeuticsMD, Inc."},"owners":[{"id":123438,"kind":"person","name":"MUSING JULES A.","position":1,"cik":"0001524216","reported_name":"MUSING JULES A.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Non-Qualified Stock Option (right to buy)","published_at":"2016-12-23T00:07:15.000Z","date":"2016-12-21","kind":"grant","acquired":true,"shares":25000,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":25000,"derivative":{"exercise_price":5.68,"exercise_date":"2017-12-21","expiration_date":"2026-12-20","underlying":"Common Stock","underlying_shares":25000},"source":{"system":"sec-edgar","filing":"0001387131-16-008706","document":"musing-form4_12212016.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/25743/000138713116008706/musing-form4_12212016.xml","form_type":"4"}}]}